To the fast-swelling ranks of ataraxic (tranquilizing) drugs, another was added last week for patients with relatively mild emotional disorders. Offered hopefully to compete with meprobamate (Miltown or Equanil), runaway bestseller among tranquilizers (TIME, Feb. 27), proclorperazine will be sold on prescription by Philadelphia's Smith, Kline & French Laboratories under the brand name Compazine.
Used in low doses and for no more than about two weeks, proclorperazine is reported to give prompt tranquility to 86% of patients suffering from anxiety, agitation, agitated depression, tension, confusion, restlessness, senile agitation and alcoholic delirium. It lets...
To continue reading:
or
Log-In
